Highlights of the AAPS 2024 Summer Scientific Forum

In this episode, we discuss the history of the AAPS Summer Scientific Forum, highlights from the 2024 event, and its goals for the future.

In this podcast episode, titled ‘Highlights of the AAPS 2024 Summer Scientific Forum’, we will be discussing the conferences’ history, as well as its goals for the future.

This conversation features Lynn Kamen, Scientific Officer, Executive Director at BioAgilytix, and Sachin Lohani, Executive Director at Eli Lilly and Company.

Key discussion points:

• What differentiates this AAPS conference from both NBC and PharmSci 360
• The implementation of new technologies for bioanalysis
• Analytical approaches for novel modalities, such as macrocyclic peptides, small proteins, lipid nanoparticles, and charged variants.
• How the Forum fosters community with their scientific attendees